Ethical sales and marketing update

Lotus Healthcare Corp. began selling in China ETHCY's twice-daily sustained release morphine product, SRM-Rhotard, to treat severe pain.

ETHCY (Godmanchester, U.K.) has taken a minority equity position in Lotus, which is developing a group of health care manufacturing and marketing joint ventures in China. The other partners in the first joint venture, which will market SRM-Rhotard, are the major domestic supplier of bulk narcotics and the China National Pharmaceutical Industry Corp., one of the principal government agencies responsible for pharmaceutical manufacturing. ...